PubRank

Kazunobu Ouchi

Author PubWeight™ 50.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother 2004 2.84
2 ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2007 2.77
3 A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 2012 1.58
4 Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet 2010 1.20
5 Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients. Respirology 2012 1.17
6 Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients. Antimicrob Agents Chemother 2013 1.15
7 Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol 2007 1.14
8 Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization. Med Sci Monit 2008 1.12
9 Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia. BMC Infect Dis 2012 1.10
10 Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age. J Infect Chemother 2010 1.03
11 Atelectasis caused by macrolide-resistant Mycoplasma pneumoniae pneumonia in an adult patient. J Infect Chemother 2013 0.96
12 Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing. BMC Med Imaging 2009 0.92
13 Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. Antimicrob Agents Chemother 2013 0.91
14 Prevalence of antibodies against Simkania negevensis in a healthy Japanese population determined by the microimmunofluorescence test. FEMS Immunol Med Microbiol 2005 0.91
15 Outbreak of Chlamydophila pneumoniae infection in long-term care facilities and an affiliated hospital. J Med Microbiol 2005 0.89
16 Japanese Guidelines for the Management of Respiratory Infectious Diseases in Children 2007 with focus on pneumonia. Pediatr Int 2011 0.89
17 Absence of Chlamydia psittaci in ocular adnexal lymphoma from Japanese patients. Br J Haematol 2006 0.87
18 Outbreak of pertussis in a university laboratory. Intern Med 2011 0.86
19 Aspirin inhibits Chlamydia pneumoniae-induced NF-kappa B activation, cyclo-oxygenase-2 expression and prostaglandin E2 synthesis and attenuates chlamydial growth. J Med Microbiol 2003 0.86
20 CD40 ligand gene and Kawasaki disease. Eur J Hum Genet 2004 0.85
21 Evaluation of serological tests detecting Chlamydophila pneumoniae-specific immunoglobulin M antibody. Intern Med 2006 0.83
22 Influence of age on the clinical differentiation of atypical pneumonia in adults. Respirology 2012 0.82
23 Adolescent jump case in Japan associated with influenza but not oseltamivir. Pediatr Infect Dis J 2008 0.82
24 Evaluation of the diagnostic usefulness of real-time PCR for detection of Chlamydophila pneumoniae in acute respiratory infections. J Infect Chemother 2007 0.82
25 Effects of antiasthma drugs on the growth of Chlamydophila pneumoniae in HEp-2 cells. J Infect Chemother 2003 0.81
26 Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy. Antimicrob Agents Chemother 2013 0.81
27 Sivelestat relieves respiratory distress refractory to dexamethasone in all-trans retinoic acid syndrome: a report of two cases. Eur J Haematol 2006 0.81
28 Diagnostic value of symptoms and laboratory data for pertussis in adolescent and adult patients. BMC Infect Dis 2013 0.81
29 Evaluation of serological tests for diagnosis of Bordetella pertussis infection in adolescents and adults. Respirology 2011 0.81
30 High serum arginase I levels in asthma: its correlation with high-sensitivity C-reactive protein. J Asthma 2010 0.80
31 Factor XIII in Henoch-Schönlein purpura with isolated gastrointestinal symptoms. Pediatr Int 2006 0.80
32 The effect of inhaled corticosteroids on Chlamydophila pneumoniae and Mycoplasma pneumoniae infection in children with bronchial asthma. J Infect Chemother 2009 0.80
33 Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): differences between a teaching university hospital and a community hospital. Intern Med 2012 0.80
34 A practical approach estimating etiologic agents using real-time PCR in pediatric inpatients with community-acquired pneumonia. J Infect Chemother 2012 0.80
35 Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia. Int J Antimicrob Agents 2010 0.79
36 Development of a novel functional high-throughput screening system for pathogen effectors in the yeast Saccharomyces cerevisiae. Biosci Biotechnol Biochem 2009 0.79
37 Assay of Chlamydia pneumoniae-specific IgM antibodies by ELISA method--reduction of non-specific reaction and resetting of serological criteria by measuring IgM antibodies--. Jpn J Infect Dis 2009 0.79
38 Comparison of serological tests for detection of immunoglobulin M antibodies to Chlamydophila pneumoniae. Respirology 2008 0.78
39 Rapid and simple diagnosis of Chlamydophila pneumoniae pneumonia by an immunochromatographic test for detection of immunoglobulin M antibodies. Clin Vaccine Immunol 2008 0.78
40 Outbreak of Chlamydia pneumoniae infection in a Japanese nursing home, 1999-2000. Infect Control Hosp Epidemiol 2006 0.78
41 Genomic screening for Chlamydophila pneumoniae-specific antigens using serum samples from patients with primary infection. FEMS Microbiol Lett 2012 0.78
42 Chest computed tomography for the diagnosis of Mycoplasma pneumoniae infection. Respirology 2013 0.77
43 Factors improving the propagation of Simkania negevensis strain Z in cell culture. Jpn J Infect Dis 2004 0.77
44 In vitro activities of 11 antimicrobial agents against macrolide-resistant Mycoplasma pneumoniae isolates from pediatric patients: results from a multicenter surveillance study. Jpn J Infect Dis 2012 0.77
45 [Pharmacokinetic and clinical studies on teicoplanin for sepsis by methicillin-cephem resistant Staphylococcus aureus in the pediatric and neonate field]. Jpn J Antibiot 2002 0.77
46 Transmission of macrolide-resistant Mycoplasma pneumoniae within a family. J Infect Chemother 2013 0.77
47 [The JAID/JSC Guideline to Clinical Management of Infectious Diseases (Respiratory infections)]. Kansenshogaku Zasshi 2014 0.77
48 In vitro inhibitory effects of hinokitiol on proliferation of Chlamydia trachomatis. Antimicrob Agents Chemother 2005 0.77
49 Knowledge, attitudes, and practices of Japanese travelers on infectious disease risks and immunization uptake. J Travel Med 2010 0.77
50 Evaluation of serological tests for diagnosis of Chlamydophila pneumoniae pneumonia in patients with nursing and healthcare-associated pneumonia. J Infect Chemother 2012 0.76
51 Chlamydophila pneumoniae serology: cross-reaction with Mycoplasma pneumoniae infection. J Infect Chemother 2012 0.76
52 Results of a multicenter survey of diagnosis and treatment for bacterial meningitis in Japan. J Infect Chemother 2010 0.76
53 Biosynthesized tea polyphenols inactivate Chlamydia trachomatis in vitro. Antimicrob Agents Chemother 2005 0.76
54 A case of meningoencephalitis associated with macrolide-resistant Mycoplasma pneumoniae infection. Pediatr Int 2012 0.75
55 Mycoplasma pneumoniae pneumonia in the elderly. Med Sci Monit 2008 0.75
56 Chlamydia pneumoniae infection as a risk factor for subarachnoid hemorrhage. Cerebrovasc Dis 2005 0.75
57 Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015. Emerg Infect Dis 2017 0.75
58 Evaluation of false-positive reaction with ELISA for the detection of Chlamydophila pneumoniae-specific IgM antibody in adults. Jpn J Infect Dis 2010 0.75
59 [Long effect of a booster on rubella antibodies from each original HI titer following vaccination]. Kansenshogaku Zasshi 2014 0.75
60 Changes in rotavirus genotypes before and after vaccine introduction: a multicenter, prospective observational study in three areas of Japan. Jpn J Infect Dis 2017 0.75
61 Natural alteration of antibody titers in a patient with immunoglobulin A deficiency after chickenpox over a 10-year period. Pediatr Int 2011 0.75
62 Ehlers-Danlos syndrome, vascular type: a novel missense mutation in the COL3A1 gene. Congenit Anom (Kyoto) 2012 0.75
63 Varicella-zoster virus-specific, cell-mediated immunity with interferon-gamma release assay after vaccination of college students with no or intermediate IgG antibody response. J Med Virol 2014 0.75
64 [Safety and efficacy in two-dose vaccination using measles and rubella combined (MR) vaccine]. Kansenshogaku Zasshi 2008 0.75
65 [Yersinia pseudotuberculosis type 4a infection meeting the diagnostic criteria for Kawasaki disease complicated by disseminated intravascular coagulation]. Kansenshogaku Zasshi 2005 0.75
66 [Pediatric bacterial meningitis prognosis and antibiotic treatment]. Kansenshogaku Zasshi 2011 0.75
67 [How to optimize oral antibiotics treatment for the pediatric respiratory tract infections--based on the guidelines for the management of respiratory infectious diseases in children in Japan 2011]. Jpn J Antibiot 2013 0.75
68 [What EIA assay levels correspond to rubella antibody HI assay titer?]. Kansenshogaku Zasshi 2009 0.75
69 Evaluation of enzyme-linked immunosorbent assay for Chlamydophila pneumoniae-specific immunoglobulin M in acute respiratory tract infection. Respirology 2008 0.75
70 [Effect of new oral antimicrobial agents in outpatient treatment of pneumonia in children]. Jpn J Antibiot 2014 0.75